← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2005Last known activity
Mar 2, 2022
Timeline
2000s
- Jan 1, 2005
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente— Founded
Drugs by trial phase (20 distinct, 14 trials)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Indications
Recent trials (18)
- NCT05382741CollaboratorPhase 2Mar 2, 2022
- NCT04793932CollaboratorPhase 2Nov 3, 2020
- NCT02043730Lead sponsorPhase 2Jan 1, 2014
- NCT01853813Lead sponsorPhase 2May 1, 2013
- NCT02076594Lead sponsorPhase 3Jan 1, 2013
- NCT01543412Lead sponsorPhase 2Jan 1, 2010
- NCT01030042Lead sponsorPhase 3Sep 1, 2009
- NCT00526643Overall official - principal investigatorPhase 3Nov 1, 2007
- NCT00526643CollaboratorPhase 3Nov 1, 2007
- NCT00758381Lead sponsorPhase 2Aug 1, 2007
- NCT00646607Lead sponsorPhase 3Jun 1, 2007
- NCT00646607Overall official - principal investigatorPhase 3Jun 1, 2007
- NCT00646607Study chairPhase 3Jun 1, 2007
- NCT00536614Lead sponsorPhase 2May 1, 2005
- NCT00536614Study chairPhase 2May 1, 2005
Details
- Founded
- Vanzago, IT Jan 1, 2005
- Last known activity
- Mar 2, 2022